ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

KMK Kromek Group Plc

6.05
0.00 (0.00%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Kromek Group Plc LSE:KMK London Ordinary Share GB00BD7V5D43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.05 5.80 6.30 6.05 6.05 6.05 109,127 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Miscellaneous Metal Ores,nec 17.31M -6.1M -0.0102 -5.93 36.31M
Kromek Group Plc is listed in the Miscellaneous Metal Ores sector of the London Stock Exchange with ticker KMK. The last closing price for Kromek was 6.05p. Over the last year, Kromek shares have traded in a share price range of 3.15p to 8.25p.

Kromek currently has 600,247,000 shares in issue. The market capitalisation of Kromek is £36.31 million. Kromek has a price to earnings ratio (PE ratio) of -5.93.

Kromek Share Discussion Threads

Showing 5251 to 5273 of 7300 messages
Chat Pages: Latest  220  219  218  217  216  215  214  213  212  211  210  209  Older
DateSubjectAuthorDiscuss
08/9/2021
21:07
Retirementfund. Is that all you have to say to answer QuePassa’s detailed blog. Log off pal and go back o bed.
b00mb0y
08/9/2021
21:07
It’s pretty normal quepassa for a company developing a lot of new class leading products not to be profitable. The various products they have developed so far will produce a small profit this financial year. Meanwhile on the side they have developed the biological pathogen detector whilst generating that small profit for the year. Here are some other facts...

Order book covers 75 per cent of revenue estimates for 2021/22 financial year.

£20m worth of nuclear sector revenue in active procurement that could be delivered this year.

Estimated turnover of £15m this year.

House broker Cenkos Securities expects gross margins to rise from 48 to 52 per cent, so with the benefit of a relatively fixed cost base last year’s Covid-19 impacted cash loss of £1.7m is forecast to produce a small adjusted cash profit.

Hill at Equity Development values the annual global market for the biological threat detection devices at £500m.

aqc888
08/9/2021
21:02
@dixter. Thought you had filtered me.
“ Just a sample. So what part of that is not informed and relevant information that could provide significant tailwind to the company that we are invested in?”
“Could” is a little bit like “if”. hmmm
Are you gambling on the “could’s”, dixter?

b00mb0y
08/9/2021
20:56
AQC. Your post 5092, along with nearly all your posts have been interesting to read and inline with my views in the main. However, this is now becoming a bit ridiculous (and I don’t mean you or your posts) to say the least. There’s no need here to reiterate over everything but all positive posts about KMK on this site have become nothing but massive ramping. In all those posts (ramping posts) there is the word “if” and they’re always massive IF’s. This is not meant as a jibe to you but to all the pathetic ramping that’s being written here.
As I said earlier, I’m gambling on the massive IF’s.
Good luck!

b00mb0y
08/9/2021
20:52
What is the brokers forecast for next year. I suspect this is more important than the last 7 years. All in my opinion.
retirementfund
08/9/2021
20:35
oh I do apologise if you feel my posts are lacking substance.

I hope this one of mine from earlier this year on 6th April 2021 (post 4244) helps rectify the situation. Perhaps you weren't on the board at the time or missed it.





"Using figures from Equity Development (7/10/20), this is Kromek's seven year performance.

Rounded by me to nearest half-million.


1. TURNOVER FIGURES.

2014 £6m
2015 £8m
2016 £8.5m
2017 £9m
2018 £12m
2019 £14.5m
2020 £13m


These TURNOVER figures include PRODUCT and OTHER.

I assume (but am not certain) that OTHER includes/means grants and research funding. For example, in 2016 OTHER was £3m. In 2019 OTHER was £2.5m



TURNOVER total for last 7 years is £71 million.


2. PROFIT BEFORE TAX - ADJUSTED

2014 -£4.5m LOSS
2015 -£3m LOSS
2016 -£4m LOSS
2017 -£4m LOSS
2018 -£2.5m LOSS
2019 -£1.5m LOSS
2020 -£4m LOSS


LOSS BEFORE TAX (ADJUSTED) for last seven years is £23.5 million.


3. EQUITY RAISING SINCE IPO

30/7/15 £11million
25/1/17 £21million
12/2/19 £21million
12/2/21 £13million


They had raised £53m by end 2020. And the new 2021 Placing, brings total to £66m.

A great deal of shareholder dilution.


4.

SUMMARY. SEVEN YEARS

TURNOVER £71m
LOSS £23.5m
EQUITY RAISINGS £53m (+ another £13m in 2021)



Where does so much money go?

With so many positive messages and so many sure-fire guaranteed, copper-bottomed, game-changer, cutting-edge, state-of-the-art and innovative whizzbang new product initiatives, mostly announced to piggy-back off the latest global scare (nuclear detection, airport security, medical imaging, ventilators ,covid), why does this company still make such resolute losses?


The Easter weekend marked the 7th. anniversary of the infamous 4/4/14 RNS announcement of the seven year up to $159million CZT-based detection modules contract in China.



You see, if you add together ALL Kromek's TURNOVER for the last seven years, the whole lot doesn't come anywhere close to what that ONE SINGLE CONTRACT was meant to bring in.

ALL IMO. DYOR.
QP

"



ALL IMO. DYOR.
QP

quepassa
08/9/2021
20:15
Fevered hype?? If you look back at the posts that you are referring to they reference articles or news that's relevant to the field that Kromeks operates.Examples Millions of dollars into US bio detection and early warning.Reports of calls for government to protect schools with bio detection.Just a sample. So what part of that is not informed and relevant information that could provide significant tailwind to the company that we are invested in?It informs other holders on the general sentiment and enviroment that Kromek operates. How they interpret that information is for them. So less of your fevered hype pish. I'm yet to see what if any you and that other boom boy fella offer ,other than glib and idle comments about mismanagement.As many have said, contrary views are welcome and needed for balance. If they have any substance or logic.....I'm still waiting to see any from both of you.
dexter1612
08/9/2021
19:45
Losing faith? Well any AIM company boomboy is slightly off-piste with higher risks and requires faith. They also come with higher rewards, navigating your way through the limited information is what makes these forums more interesting. I think it’s fair to say the unknowns around Kromek are what is causing the irrational exuberance and fear, with the share price surging and falling every few months. As I always say regarding Kromek, the management seem a little poor. But what we’re all here for is the potential scientific achievements of its scientists in developing the biological pathogen detector, which will be largely patented and years ahead of rivals in an area which is of huge importance to many nations and institutions around the world at the moment (bio-terrorism & pandemic). If Kromek achieves what we’re hoping for it will have a substantial economic moat around its biological pathogen detector. When losing faith you’ve got to remember the track record of Kromeks scientists, which are first class, from their leading medical scanners, leading award winning security x-ray scanners & leading radiation detectors. Kromeks scientists clearly have the ability to produce first class products and if they manage to pull off this biological pathogen detector it’s going to be huge.
aqc888
08/9/2021
17:52
b00mb0y not a chance your the one spouting unresearched tripe. Happy to see how it plays out I am very comfortable with my investment and level of research. All in my opinion
retirementfund
08/9/2021
17:26
so no news then about the covid sniffer thingamajig.

doesn't surprise me despite all the fevered hype from multiple posters over the last several weeks.

Post 5086 is a bull's-eye.

all imo. dyor.
qp

quepassa
08/9/2021
17:08
Oh, by the way, retirementfund. What’s your researched opinion on KMK then. Let’s have it please.
b00mb0y
08/9/2021
16:42
You could well lose your retirement funding here. I hope you don’t.
Is this your first post?
Please go back to school and learn to write.

b00mb0y
08/9/2021
16:39
b00mb0y I must admit if nothing else you add comedy value. I suspect if you a capable go away research Kmk and then come back as you as currently your not really credible. All in my opinion
retirementfund
08/9/2021
16:31
Aqc…… “I’m satisfied with my holding as Kromek are valued at 24p by equity development without the detector.”
That means jack sh1t. The share price and the market tells us otherwise.

“Seems like there may well be no news on the biological pathogen detector till the end of the year”
and yet we were told “in the coming days” by Arnab in March. (Promises,promises)
“ Even if the biological pathogen detector doesn’t work you’re only going to make modest losses, if any.
It sounds to me like you are also losing faith, Aqc.

Fruitloops “ Barring a major upset like a shareholder rebellion, AGMs are rarely of much consequence.” then why was everyone waiting for today and blogging about it with eagerness?

Deedledee “ Can anyone summarise the AGM outcome? Share price has dipped. Why?”
Because faith has all but totally gone! This share is now a massive gamble. If (a big IF) it comes good then great but a massive gamble!
I’m gambling on the Big IF!

b00mb0y
08/9/2021
15:39
nevertheless its disappointing! mind you, the mkts are red everywhere!
abbynat
08/9/2021
13:47
Investors are probably a bit unnerved by the lack of information regarding the trials and quite a lot of unknowns regarding the detector. Not much definitive information seems to be released, I’d suspect the share price will continue to drift lower and stay between 15-19p. I’m satisfied with my holding as Kromek are valued at 24p by equity development without the detector. The rest of the business should perform better than it has for years due to the increased nuclear spending due to rise in instability in Afghanistan and the huge rise in the U.K. government nuclear spending previously mentioned. The medical scanner business is also performing better than it has in years. Even if the biological pathogen detector doesn’t work you’re only going to make modest losses, if any. The upside if the detector does work is huge however. Seems like there may well be no news on the biological pathogen detector till the end of the year
aqc888
08/9/2021
13:32
The answers I got from the FD were very positive on barriers to entry for the bio- threat machines, patent protection and the two year head start on competitors who can’t test in automated real time at present.

As you astutely observed AQ, the answer to when the bio-threat are commercially available seems to have lengthened from this calendar year to this fiscal year. I’d say that means first qtr next year.

A patient hold for me and it is one of those stocks where patience is needed.

I’d just ignore the slightly inane posts that shed more heat than light on the prospects.

nick2412
08/9/2021
13:20
Barring a major upset like a shareholder rebellion, AGMs are rarely of much consequence.
fruitloops101
08/9/2021
12:47
Can anyone summarise the AGM outcome? Share price has dipped. Why?
deedledee
08/9/2021
12:43
Is Quepassa for real !! bizarre …
strategicinvestor2
08/9/2021
12:41
Quepassa, the answer is a big fat zero. The same as all the other before mentioned companies, for the before mentioned reasons.

The only thing I agree with you about is your ‘yawn’ comment

aqc888
08/9/2021
12:35
Yawn.

We are talking about GLOBAL SALES - sales away from the UK-

and there you have no legs to stand on

quepassa
08/9/2021
12:23
Ford, RR & Kromek all were involved in the before mentioned U.K. ventilator challenge (along with dozens of other institutions). They all produced zero ventilators...
aqc888
Chat Pages: Latest  220  219  218  217  216  215  214  213  212  211  210  209  Older

Your Recent History

Delayed Upgrade Clock